1 |
Dhar, A., Young, M. R. and Colburn, N. H. (2002). The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell Biochem. 234-235, 185-193
DOI
ScienceOn
|
2 |
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y. and Collins, T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94, 2927-2932
DOI
|
3 |
Hollingsworth, J. W., Whitehead, G. S., Lin, K. L., Nakano, H., Gunn, M. D., Schwartz, D. A. and Cook, D. N. (2006). TLR4 signaling attenuates ongoing allergic inflammation. J. Immunol. 176, 5856-5862
DOI
|
4 |
Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulga-Morskaya, S., Dobles, M., Frew, E. and Scott, M. L. (2001). An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114
DOI
ScienceOn
|
5 |
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L. (1999). Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697-1710
DOI
|
6 |
Moon, E. Y., Han, Y. H., Lee, D. S., Han, Y. M. and Yu, D. Y. (2004). Reactive oxygen species induced by the deletion of peroxiredoxin II (PrxII) increases the number of thymocytes resulting in the enlargement of PrxII-null thymus. Eur. J. Immunol. 34, 2119-2128
DOI
ScienceOn
|
7 |
Ostergaard, P. A. (1985). Non-IgE-mediated asthma in children. Acta. Paediatr. Scand. 74, 713-719
DOI
|
8 |
Tai, Y. T., Li, X. F., Breitkreutz, I., Song, W., Neri, P., Catley, L., Podar, K., Hideshima, T., Chauhan, D., Raje, N., Schlossman, R., Richardson, P., Munshi, N. C. and Anderson, K. C. (2006). Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res. 66, 6675-6682
DOI
ScienceOn
|
9 |
Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M. G. and Packer, L. (1997). Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22, 1115-1126
DOI
ScienceOn
|
10 |
Corrigan, C. (2004). Mechanisms of intrinsic asthma. Curr. Opin. Allergy Clin. Immunol. 4, 53-56
DOI
ScienceOn
|
11 |
Fu, L., Lin-Lee, Y. C., Pham, L. V., Tamayo, A., Yoshimura, L. and Ford, R. J. (2006). Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107, 4540-4548
DOI
ScienceOn
|
12 |
Mackay, F., Schneider, P., Rennert, P. and Browning, J. (2003). Baff and april: a tutorial on B cell survival. Annu. Rev. Immunol. 21, 231-264
DOI
ScienceOn
|
13 |
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S. (1998). Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150
DOI
ScienceOn
|
14 |
Akira, S., Yamamoto, M. and Takeda, K. (2003). Role of adapters in Toll-like receptor signaling. Biochem. Soc. Trans. 31, 637-642
DOI
|
15 |
Asehnoune, K., Strassheim, D., Mitra, S., Kim, J. Y. and Abraham, E. (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172, 2522-2529
DOI
|
16 |
Baeuerle, P. A. and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179
DOI
ScienceOn
|
17 |
Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y. H., Yu, D. Y., Park, H. S., Kim, K. Y., Lee, J. S., Choi, C., Bae, Y. S., Lee, B. I., Rhee, S. G. and Kang, S. W. (2005). Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 435, 347-353
DOI
ScienceOn
|
18 |
Mates, J. M., Perez-Gomez, C. and Nunez de Castro, I. (1999). Antioxidant enzymes and human diseases. Clin. Biochem. 32, 595-603
DOI
ScienceOn
|
19 |
Han, Y. H., Kim, H. S., Kim, J. M., Kim, S. K., Yu, D. Y. and Moon, E. Y. (2005). Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. FEBS Lett. 579, 4897-4902
DOI
ScienceOn
|
20 |
Han, Y. H., Kwon, J. H., Yu, D. Y. and Moon, E. Y. (2006). Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence. Free Radic. Res. 40, 1182-1189
DOI
ScienceOn
|
21 |
Hultmark, D. (1994). Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199, 144-146
DOI
ScienceOn
|
22 |
Janknecht, R. and Hunter, T. (1996). Transcription. A growing coactivator network. Nature 383, 22-23
DOI
ScienceOn
|
23 |
Moon, E. Y. (2008). Serum deprivation enhances apoptotic cell death by increasing mitochondrial enzyme activity. Biomol. Ther. 16, 1-8
과학기술학회마을
DOI
ScienceOn
|
24 |
Janknecht, R. and Hunter, T. (1996). Versatile molecular glue. Transcriptional control. Curr. Biol. 6, 951-954
DOI
ScienceOn
|
25 |
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829
DOI
ScienceOn
|
26 |
Lord, K. A., Hoffman-Liebermann, B. and Liebermann, D. A. (1990). Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5, 1095-1097
|
27 |
Moon, E. Y., Kang, J. S., Han, S. H., Yang, K. H., Pyo, S., Lee, M. Y., Lee, H. K. and Yu, D. Y. (2008). Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma. Int. Immunopharmacol. 8, 935-944
DOI
ScienceOn
|
28 |
Moon, E. Y., Lee, J. H., Oh, S. Y., Ryu, S. K., Kim, H. M., Kwak, H. S. and Yoon, W. K. (2006). Reactive oxygen species augment B-cell-activating factor expression. Free Radic. Biol. Med. 40, 2103-2111
DOI
ScienceOn
|
29 |
Muzio, M., Ni, J., Feng, P. and Dixit, V. M. (1997). IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615
DOI
|
30 |
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H. and Nabel, G. J. (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527
DOI
ScienceOn
|
31 |
Rackeman, F. M. (1947). A working classification of asthma. Am. J. Med. 33, 601-606
DOI
ScienceOn
|
32 |
Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B. Jr., Ritchie, T. C., Hunninghake, G. W., Zandi, E. and Engelhardt, J. F. (2001). Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J. Biol. Chem. 276, 30188-30198
DOI
ScienceOn
|
33 |
Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L. and Tschopp, J. (1999). BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756
DOI
|
34 |
Toledano, M. B. and Leonard, W. J. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidationreduction in vitro. Proc. Natl. Acad. Sci. USA. 88, 4328-4332
DOI
ScienceOn
|
35 |
Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. and Cao, Z. (1997). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847
DOI
ScienceOn
|
36 |
Zhang, H., Spapen, H., Nguyen, D. N., Benlabed, M., Buurman, W. A. and Vincent, J. L. (1994). Protective effects of N-acetyl-L-cysteine in endotoxemia. Am. J. Physiol. 266, H1746-1754
DOI
|